US 11,980,657 B2
Peptide vaccines for hypercholesterolemia related diseases
Sylvia Brunner, Vienna (AT); Gergana Galabova, Vienna (AT); Gabriele Winsauer, Vienna (AT); Erika Bilcikova, Bratislava (SK); Claudia Juno, Vienna (AT); Pola Linzmayer-Hirt, Wiener Neudorf (AT); Birgit Schuh, Vienna (AT); and Guenther Staffler, Vienna (AT)
Assigned to AFFIRIS CVD GMBH, Vienna (AT)
Filed by AFFIRIS CVD GMBH, Vienna (AT)
Filed on Jan. 11, 2021, as Appl. No. 17/145,571.
Application 17/145,571 is a continuation of application No. 15/984,800, filed on May 21, 2018, granted, now 10,933,123.
Application 15/984,800 is a continuation of application No. 15/367,711, filed on Dec. 2, 2016, granted, now 9,999,659.
Application 15/367,711 is a continuation of application No. 14/418,139, granted, now 9,533,030, previously published as PCT/EP2013/067797, filed on Aug. 28, 2013.
Claims priority of application No. 12182241 (EP), filed on Aug. 29, 2012.
Prior Publication US 2021/0138048 A1, May 13, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 39/00 (2006.01); A61K 39/385 (2006.01); A61K 39/39 (2006.01); A61K 47/64 (2017.01); C12N 9/64 (2006.01)
CPC A61K 39/0005 (2013.01) [A61K 39/385 (2013.01); A61K 39/39 (2013.01); A61K 47/6415 (2017.08); A61K 47/643 (2017.08); A61K 47/646 (2017.08); C12N 9/6424 (2013.01); C12N 9/6454 (2013.01); C12Y 304/21061 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/6081 (2013.01)] 7 Claims
 
1. A vaccine comprising at least one peptide, wherein the at least one peptide is selected from the group consisting of TIPWNLERIT (SEQ ID NO. 5), VIPWNLERIT (SEQ ID NO. 6), AIPWNLERIT (SEQ ID NO. 7), SVPWNLERIT (SEQ ID NO. 8), SQPWNLERIT (SEQ ID NO. 9), SAPWNLERIT (SEQ ID NO. 10) SIPWALERIT (SEQ ID NO. 22), SIPWQLERTIPPR (SEQ ID NO. 23), SIPWDLERITPPR (SEQ ID NO. 24), SIPWNLDRITPPR (SEQ ID NO. 32), SIPWNFERIT (amino acids 1-10 of SEQ ID NO. 29), SIPWNVERIT (amino acids 1-10 of SEQ ID NO. 30), SIPWNLDRIT (amino acids 1-10 of SEQ ID NO. 32), SIPWNLERLT (SEQ ID NO. 36), SIPWNLERTT (SEQ ID NO. 37), SIPWNLERAT (SEQ ID NO. 38), SIPWNLERIL (SEQ ID NO. 39), SIPWNLERIQ (SEQ ID NO. 40), SIPWNLERIA (SEQ ID NO. 41), SIPWNLERISPPR (SEQ ID NO. 42), SIPWNLERIS (amino acids 1-10 of SEQ ID NO. 42), SIPWNLERITAPR (SEQ ID NO. 43), SIPWNLERITSPR (SEQ ID NO. 44), SIPWNLERITPAR (SEQ ID NO. 45), SIPWNLERITPVR (SEQ ID NO. 46), SIPWNLERITPTR (SEQ ID NO. 47), SIPWNLERITPNR (SEQ ID NO. 48), SIPWNLERITPPA (SEQ ID NO. 49), SIPWNLERITPPK (SEQ ID NO. 50), SIPWNLERITPPS (SEQ ID NO. 51), SIPWNLERITPPL (SEQ ID NO. 52), VIPWNLERLT (SEQ ID NO. 53), VIPWNLERTT (SEQ ID NO. 54), VIPWNLERIL (SEQ ID NO. 55), VIPWNLERILPPR (SEQ ID NO. 101), VIPWNLERIQ (SEQ ID NO. 56), SVPWNLERLT (SEQ ID NO. 57), SVPWNLERTT (SEQ ID NO. 58), SVPWNLERIL (SEQ ID NO. 59), SVPWNLERIQ (SEQ ID NO. 60), SVPWNLERIQPPR (SEQ ID NO. 106), SIPWSLERTTPPR (SEQ ID NO. 107), SQPWNLERLT (SEQ ID NO. 61), SQPWNLERIL (SEQ ID NO. 62), SQPWNLERIQ (SEQ ID NO. 63), SIPWSLERLT (SEQ ID NO. 64), SIPWSLERTT (SEQ ID NO. 65), SIPWSLERIL (SEQ ID NO. 66), SIPWSLERIQ (SEQ ID NO. 67), VQPWSLERTL (SEQ ID NO. 68), SQPWSLERTL (SEQ ID NO, 69), VQPWNLERLQ (SEQ ID NO. 71), VQPWSLERLL (SEQ ID NO. 72) and SVPWSLERLT (SEQ ID NO. 73).